Future Science Group introduces new open access journal on concussion

NewsGuard 100/100 Score

Future Science Group (FSG) has launched Concussion, a new open access journal that publishes original research, reviews and commentaries addressing the assessment, management and short and long term implications of this subset of traumatic brain injury, which is gaining increasing attention.

"As professional sports leagues and parents of young athletes alike are placing more emphasis on concussion prevention and protocol, exciting developments in biomarker research are shedding new light on how to gauge the severity of concussions immediately after injury, as well as indicating future prognosis," said Commissioning Editor Hannah Wilson. "Using the open access model, we hope to make the latest advances in basic, translational and clinical research in the field available to the broadest possible audience of readers."

Topics covered by Concussion include:

  • Studies and trials in concussion
  • Biomarkers for assessment and predicting adverse effects

  • Optimum biomarker selection, validation and application

  • Management, including return-to-play decisions in sports

  • Pathogenesis

  • Pathology

  • Prognosis

Concussion will be supported by an international editorial board consisting of leading experts in the field. Board member Steven P. Broglio, University of Michigan, MI, USA explained: "Concussions have become a critical public health issue, resulting in a substantial increase in research. For a clinician searching for the most up-to-date information, Concussion can serve as the go-to journal."

The journal will consider publication of original research, review and opinion articles. All articles submitted to Concussion are subject to peer review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP2. The journal follows a gold open access model, publishing all articles under the Creative Commons CC-BY license to allow maximum dissemination.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough brain stimulator could revolutionize treatment for neurological disorders